Your cart

Your cart is empty

Prescribe via the SAS-B Pathway for Doctors

Regular price $39.00
Unit price
per 

    • Overview

      While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway. 

      We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.

      Preview this course by watching the video above.

      Estimated Duration: 1 hour

      Access Duration: 12 months from date of purchase

      Learning Outcomes

      Upon completion of this course, you’ll be able to:

      • Define unapproved good
      • Describe different pathways for accessing and prescribing unapproved goods
      • Explain the differences and correct use of the SAS and Authorised prescriber pathways
      • Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
      • Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway

    Overview

    While medical cannabis is an effective treatment option for many patients, it’s considered an unapproved good on the TGA’s schedule of drugs. This course is designed to equip healthcare professionals with the skills, knowledge and confidence to navigate the TGA’s Special Access Scheme (SAS) and apply to prescribe medical cannabis to suitable individual patients on a case by case basis using the SAS-B pathway. 

    We’ll also delve into the broader legal and ethical considerations of prescribing medical cannabis as a treatment option, including risk-mitigation strategies so you can start prescribing medical cannabis to your eligible patients as soon as possible.

    Preview this course by watching the video above.

    Estimated Duration: 1 hour

    Access Duration: 12 months from date of purchase

    Learning Outcomes

    Upon completion of this course, you’ll be able to:

    • Define unapproved good
    • Describe different pathways for accessing and prescribing unapproved goods
    • Explain the differences and correct use of the SAS and Authorised prescriber pathways
    • Apply to prescribe medical cannabis for individual patients using the SAS-B pathway
    • Explain the legal and ethical considerations, and risk-mitigation strategies when prescribing medical cannabis via the SAS-B pathway